For peripheral inflammation, it has been shown that disruption of the expression and activation of the IL-17RA/IL-17RC complex on Th17 cells increases IL-17A production and leads to an accelerated course of experimental sickle-shaped glomerulonephritis, psoriasis, and colitis [126]. The gene discussed is IL17A; the disease is psoriasis.